Company / Capital Returned to Shareholders
Medtronic Capital Returned to Shareholders History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$5.8B
FY2026
5-year range
$3.8B / $6.8B
FY2022-FY2026
Trend
+36.2%
vs FY2025
Sector context
#3 of 108
Health Care
What the data says
Among 108 Health Care companies, Medtronic is in the top 3% for capital returned to shareholders. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $3.8B in FY2023 to $6.8B in FY2024.
Based on SEC 10-K filings.
$5.8B in FY2026 with a 5-year CAGR of +0.8%. Ranks 3rd among 108 companies in Health Care.
Declined from $6.8B to $5.8B over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +15.4%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 108This company $5.8B Sector average $754.9M
▼
+668.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2026, capital returned to shareholders increased 36.2% year-over-year.
- Ranks #3 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2024.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $5.8B | +36.2% |
| FY2025 | $4.3B | -37.6% |
| FY2024 | $6.8B | +80.9% |
| FY2023 | $3.8B | -10.6% |
| FY2022 | $4.2B | -24.2% |
| FY2021 | $5.6B | +47.7% |
| FY2020 | $3.8B | -10.6% |
| FY2019 | $4.2B | -24.2% |
| FY2018 | $5.6B | +19.4% |
| FY2017 | $4.7B | -21.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026